G蛋白结合受体35具有潜在的潜力,作为治疗冠状骨肉瘤的希望之灯
1Department of Medical Biochemistry, Faculty of Medicine, Cyprus Health and Social Sciences University, Morphou, Northern Cyprus.
Balkan journal of medical genetics : BJMG
|November 7, 2025
概括
比萨科迪尔显示出作为一种罕见的骨癌 - - 冠状动脉瘤的治疗剂的潜力. 这项研究确定了bisacodyl作为一种针对性治疗冠状腺癌细胞系的治疗方法,为患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 软骨生物学 软骨生物学
- 癌症遗传学 癌症遗传学
背景情况:
- Dagiti chondrosarcomas ket dagiti kangrunaan a kangker ti tulang nga addaan ti neoplastic hyaline cartilage.
- 传统的冠状腺瘤对常规治疗具有抗性,导致复发后的预后不佳.
- 在了解冠状腺癌生物学,遗传学和表观遗传学方面的最新进展正在揭示潜在的治疗点.
研究的目的:
- 为了确定潜在的针对性治疗冠状骨肉瘤.
- 为了评估bisacodyl作为一种治疗药物对抗冠状腺癌细胞系.
- 为了探索G蛋白结合受体在软骨肉瘤治疗中的作用.
主要方法:
- 在使用Gene2药物和DSEA的选中.
- 从DepMap数据库中提取抗瘤活动.
- 通过PRISM活力测试对八种冠状腺癌细胞系进行抗瘤活性评估.
主要成果:
- 鉴定了比萨科迪尔作为针对G蛋白结合受体35的向剂.
- 比萨科迪尔在软骨肉瘤细胞系中表现出显著的抗瘤活性.
- G蛋白结合受体被认为是癌症治疗的可行标.
结论:
- 比萨科迪尔 (bisacodyl) 是一种有前途的治疗候选物,用于治疗软骨肉瘤.
- 聚焦于G蛋白结合受体的向疗法为冠状腺癌治疗提供了一条新的途径.
- 需要进一步研究bisacodyl在软骨肉瘤中的疗效和机制.
相关概念视频
01:15G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
01:21G-protein Coupled Receptors
131.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:30Transducer Mechanism: G Protein–Coupled Receptors
3.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.9K